BIOMAT Database Logo BIOMAT Database Logo

Allelic imbalance at the HER2/TOP2A locus in breast cancer. 2015

Cornelis J J Huijsmans, and Adriaan J C van den Brule, and Henny Rigter, and Jeroen Poodt, and Johannes C van der Linden, and Paul H M Savelkoul, and Mirrian Hilbink, and Mirjam H A Hermans
Laboratory of Molecular Diagnostics, Jeroen Bosch Hospital, PO Box 90153, 5200 ME, 's-Hertogenbosch, The Netherlands. r.huysmans@jbz.nl.

BACKGROUND Breast cancer is a heterogeneous disease with various histological features and molecular markers. These are utilized for the prediction of clinical outcome and therapeutic decision making. In addition to well established markers such as HER2 overexpression and estrogen and progesterone receptor (ER and PR) status, chromosomal instability is evolving as an important hallmark of cancers. The HER2/TOP2A locus is of great importance in breast cancer. The copy number variability at this locus has been proposed to be a marker for the degree of chromosomal instability. We therefore developed a Single Nucleotide Polymorphism (SNP) assay to evaluate allelic imbalance at the HER2/TOP2A locus in three different entities of primary breast tumors. METHODS Eleven SNPs were carefully selected and detected by real time PCR using DNA extracted from paired (histologically normal and tumor) paraffin-embedded tissues. Primary breast tumors of 44 patients were included, 15 tumors with HER2 overexpression, 16 triple negative tumors, defined by the absence of HER2 overexpression and a negative ER and PR status and 13 ER and PR positive tumors without HER2 overexpression. As controls, histologically normal breast tissues from 10 patients with no breast tumor were included. RESULTS Allelic imbalance was observed in 13/15 (87 %) HER2 positive tumors, the remaining 2 being inconclusive. Of the 16 triple negative tumors, 12 (75 %) displayed instability, 3 (19 %) displayed no instability, and 1 was inconclusive. Of the 13 hormone receptor positive tumors, 5 (38 %) displayed allelic imbalance, while 8 did not. CONCLUSIONS We conclude that the SNP assay is suitable for rapid testing of allelic (im)balance at the HER2/TOP2A locus using paraffin-embedded tissues. Based on allelic imbalance at this locus, both triple negative and ER and PR positive breast tumors can be subcategorized. The clinical relevance of the allelic (im)balance status at the HER2/TOP2A locus in breast cancer is subject of future study. The virtual slide(s) for this article can be found here: http://www.diagnosticpathology.diagnomx.eu/vs/2086062232155220.

UI MeSH Term Description Entries
D007150 Immunohistochemistry Histochemical localization of immunoreactive substances using labeled antibodies as reagents. Immunocytochemistry,Immunogold Techniques,Immunogold-Silver Techniques,Immunohistocytochemistry,Immunolabeling Techniques,Immunogold Technics,Immunogold-Silver Technics,Immunolabeling Technics,Immunogold Silver Technics,Immunogold Silver Techniques,Immunogold Technic,Immunogold Technique,Immunogold-Silver Technic,Immunogold-Silver Technique,Immunolabeling Technic,Immunolabeling Technique,Technic, Immunogold,Technic, Immunogold-Silver,Technic, Immunolabeling,Technics, Immunogold,Technics, Immunogold-Silver,Technics, Immunolabeling,Technique, Immunogold,Technique, Immunogold-Silver,Technique, Immunolabeling,Techniques, Immunogold,Techniques, Immunogold-Silver,Techniques, Immunolabeling
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D010641 Phenotype The outward appearance of the individual. It is the product of interactions between genes, and between the GENOTYPE and the environment. Phenotypes
D011960 Receptors, Estrogen Cytoplasmic proteins that bind estrogens and migrate to the nucleus where they regulate DNA transcription. Evaluation of the state of estrogen receptors in breast cancer patients has become clinically important. Estrogen Receptor,Estrogen Receptors,Estrogen Nuclear Receptor,Estrogen Receptor Type I,Estrogen Receptor Type II,Estrogen Receptors Type I,Estrogen Receptors Type II,Receptor, Estrogen Nuclear,Receptors, Estrogen, Type I,Receptors, Estrogen, Type II,Nuclear Receptor, Estrogen,Receptor, Estrogen
D011980 Receptors, Progesterone Specific proteins found in or on cells of progesterone target tissues that specifically combine with progesterone. The cytosol progesterone-receptor complex then associates with the nucleic acids to initiate protein synthesis. There are two kinds of progesterone receptors, A and B. Both are induced by estrogen and have short half-lives. Progesterone Receptors,Progestin Receptor,Progestin Receptors,Receptor, Progesterone,Receptors, Progestin,Progesterone Receptor,Receptor, Progestin
D001943 Breast Neoplasms Tumors or cancer of the human BREAST. Breast Cancer,Breast Tumors,Cancer of Breast,Breast Carcinoma,Cancer of the Breast,Human Mammary Carcinoma,Malignant Neoplasm of Breast,Malignant Tumor of Breast,Mammary Cancer,Mammary Carcinoma, Human,Mammary Neoplasm, Human,Mammary Neoplasms, Human,Neoplasms, Breast,Tumors, Breast,Breast Carcinomas,Breast Malignant Neoplasm,Breast Malignant Neoplasms,Breast Malignant Tumor,Breast Malignant Tumors,Breast Neoplasm,Breast Tumor,Cancer, Breast,Cancer, Mammary,Cancers, Mammary,Carcinoma, Breast,Carcinoma, Human Mammary,Carcinomas, Breast,Carcinomas, Human Mammary,Human Mammary Carcinomas,Human Mammary Neoplasm,Human Mammary Neoplasms,Mammary Cancers,Mammary Carcinomas, Human,Neoplasm, Breast,Neoplasm, Human Mammary,Neoplasms, Human Mammary,Tumor, Breast
D004250 DNA Topoisomerases, Type II DNA TOPOISOMERASES that catalyze ATP-dependent breakage of both strands of DNA, passage of the unbroken strands through the breaks, and rejoining of the broken strands. These enzymes bring about relaxation of the supercoiled DNA and resolution of a knotted circular DNA duplex. DNA Topoisomerase (ATP-Hydrolysing),DNA Topoisomerase II,DNA Topoisomerase II alpha,DNA Topoisomerase II beta,DNA Type 2 Topoisomerase,TOP2A Protein,TOP2B Protein,Topoisomerase II,Topoisomerase II alpha,Topoisomerase II beta,Type II DNA Topoisomerase,alpha, Topoisomerase II,beta, Topoisomerase II
D004268 DNA-Binding Proteins Proteins which bind to DNA. The family includes proteins which bind to both double- and single-stranded DNA and also includes specific DNA binding proteins in serum which can be used as markers for malignant diseases. DNA Helix Destabilizing Proteins,DNA-Binding Protein,Single-Stranded DNA Binding Proteins,DNA Binding Protein,DNA Single-Stranded Binding Protein,SS DNA BP,Single-Stranded DNA-Binding Protein,Binding Protein, DNA,DNA Binding Proteins,DNA Single Stranded Binding Protein,DNA-Binding Protein, Single-Stranded,Protein, DNA-Binding,Single Stranded DNA Binding Protein,Single Stranded DNA Binding Proteins
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

Cornelis J J Huijsmans, and Adriaan J C van den Brule, and Henny Rigter, and Jeroen Poodt, and Johannes C van der Linden, and Paul H M Savelkoul, and Mirrian Hilbink, and Mirjam H A Hermans
Allelic imbalance of HER2 variant in sporadic breast and ovarian cancer.
May 2006, Cancer genetics and cytogenetics,
Cornelis J J Huijsmans, and Adriaan J C van den Brule, and Henny Rigter, and Jeroen Poodt, and Johannes C van der Linden, and Paul H M Savelkoul, and Mirrian Hilbink, and Mirjam H A Hermans
Allelic imbalance in colorectal cancer at the CRAC1 locus in early-onset colorectal cancer.
August 2003, Cancer genetics and cytogenetics,
Cornelis J J Huijsmans, and Adriaan J C van den Brule, and Henny Rigter, and Jeroen Poodt, and Johannes C van der Linden, and Paul H M Savelkoul, and Mirrian Hilbink, and Mirjam H A Hermans
Allelic imbalance in human breast cancer.
February 2017, Oncotarget,
Cornelis J J Huijsmans, and Adriaan J C van den Brule, and Henny Rigter, and Jeroen Poodt, and Johannes C van der Linden, and Paul H M Savelkoul, and Mirrian Hilbink, and Mirjam H A Hermans
Genomic analysis of the HER2/TOP2A amplicon in breast cancer and breast cancer cell lines.
May 2008, Laboratory investigation; a journal of technical methods and pathology,
Cornelis J J Huijsmans, and Adriaan J C van den Brule, and Henny Rigter, and Jeroen Poodt, and Johannes C van der Linden, and Paul H M Savelkoul, and Mirrian Hilbink, and Mirjam H A Hermans
Frequent allelic imbalance at the ATM locus in DNA multiploid colorectal carcinomas.
September 2001, Oncogene,
Cornelis J J Huijsmans, and Adriaan J C van den Brule, and Henny Rigter, and Jeroen Poodt, and Johannes C van der Linden, and Paul H M Savelkoul, and Mirrian Hilbink, and Mirjam H A Hermans
Recurrent allelic imbalance at the rat Pten locus in DMBA-induced fibrosarcomas.
January 2003, Genes, chromosomes & cancer,
Cornelis J J Huijsmans, and Adriaan J C van den Brule, and Henny Rigter, and Jeroen Poodt, and Johannes C van der Linden, and Paul H M Savelkoul, and Mirrian Hilbink, and Mirjam H A Hermans
Amplification of HER2 and TOP2A and deletion of TOP2A genes in a series of Taiwanese breast cancer.
January 2017, Medicine,
Cornelis J J Huijsmans, and Adriaan J C van den Brule, and Henny Rigter, and Jeroen Poodt, and Johannes C van der Linden, and Paul H M Savelkoul, and Mirrian Hilbink, and Mirjam H A Hermans
Allelic expression imbalance at high-density lipoprotein cholesterol locus MMAB-MVK.
May 2010, Human molecular genetics,
Cornelis J J Huijsmans, and Adriaan J C van den Brule, and Henny Rigter, and Jeroen Poodt, and Johannes C van der Linden, and Paul H M Savelkoul, and Mirrian Hilbink, and Mirjam H A Hermans
Infrequent allelic imbalance at the major susceptibility HPC1 locus in sporadic prostate tumours.
June 1997, International journal of cancer,
Cornelis J J Huijsmans, and Adriaan J C van den Brule, and Henny Rigter, and Jeroen Poodt, and Johannes C van der Linden, and Paul H M Savelkoul, and Mirrian Hilbink, and Mirjam H A Hermans
An allelic variant at the ATM locus is implicated in breast cancer susceptibility.
January 1997, Genetic testing,
Copied contents to your clipboard!